Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAkari Therapeutics, Plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2027 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q2 2027 | 1 | $1.39 | $1.39 | $1.39 |
| Q3 2027 | 1 | $2.09 | $2.09 | $2.09 |
| Q4 2027 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q1 2028 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q2 2028 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2028 | 1 | -$1.00 | -$1.00 | -$1.00 |
Akari Therapeutics, Plc Earnings Date And Information
Akari Therapeutics, Plc last posted its earnings results on Friday, December 5th, 2025. The company reported $-0.04 earnings per share for the quarter, missing analysts' consensus estimates of $-0.04 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Akari Therapeutics, Plc has generated $-1,660 earnings per share over the last year ($-1660 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Akari Therapeutics, Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 18th, 2025 based on prior year's report dates.
Akari Therapeutics, Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | N/A | -$19,480.00 | N/A | $0 | $0 |
| 08/13/2025 | Q2 2025 | N/A | -$120.40 | N/A | $0 | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$280.00 | N/A | N/A | $0 |
| 04/15/2025 | Q4 2024 | N/A | -$40.00 | N/A | N/A | $0 |
| 11/19/2024 | Q3 2024 | -$0.60 | -$240.00 | -239.4 | N/A | $0 |
| 08/19/2024 | Q2 2024 | -$1.00 | -$80.00 | -79 | N/A | $0 |
| 03/29/2024 | Q1 2024 | N/A | -$80.00 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$60.00 | N/A | N/A | $0 |
| 09/28/2023 | Q3 2023 | N/A | -$60.00 | N/A | N/A | $0 |
| 09/29/2023 | Q2 2023 | N/A | -$60.00 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | $20.00 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$100.00 | N/A | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$100.00 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$180.00 | N/A | N/A | $0 |
| 05/17/2022 | Q1 2022 | N/A | -$200.00 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$240.00 | N/A | N/A | $0 |
| 12/03/2021 | Q3 2021 | N/A | -$60.00 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$220.00 | N/A | N/A | $0 |
| 04/20/2021 | Q1 2021 | N/A | -$300.00 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$520.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akari Therapeutics, Plc Earnings: FAQ's
Akari Therapeutics, Plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 18th, 2025 based offlast year's report dates.
The conference call for Akari Therapeutics, Plc's latest earnings report can be listened to online.
The conference call transcript for Akari Therapeutics, Plc's latest earnings report can be read online.
Akari Therapeutics, Plc (:AKTX) has a recorded net income of $-19,791,000.Akari Therapeutics, Plc has generated $-1660 earnings per share over the last four quarters.
Akari Therapeutics, Plc (:AKTX) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.